This activity has been planned and implemented
in accordance with the Essential Areas and Policies of the Accreditation
Council for Continuing Medical Education through the joint sponsorship
of The Johns Hopkins University School of Medicine and The Institute for
Johns Hopkins Nursing. The Johns Hopkins University School of Medicine
is accredited by the ACCME to provide continuing medical education for
physicians.
The Institute for Johns Hopkins Nursing is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.
The Institute for Johns Hopkins Nursing and the American Nurses Credentialing Center do not endorse the use of any commercial products discussed or displayed in conjunction with this educational activity.
eNewsletter: The Johns Hopkins
University School of Medicine designates this enduring material for a
maximum of 1.0 AMA PRA Category1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in
the activity.
Podcast: The Johns Hopkins University School
of Medicine designates this enduring material for a maximum of 0.75 AMA PRA Category1 Credit(s)™. Physicians should claim only the credit
commensurate with the extent of their participation in the activity.
eNewsletter: This 1 contact
hour Educational Activity is provided
by the Institute for Johns Hopkins Nursing.
Each Newsletter carries a maximum
of 1 contact hours or a total of 7 contact hours for the seven newsletters
in
this program. To obtain contact hours, you must complete this Education Activity and post-test before
July 24, 2013.
Podcast: These paired 0.5 contact hour Educational
Activities are provided by the Institute
for Johns Hopkins Nursing. Each podcast carries a maximum of 0.5 contact
hours or a total of 2.5 contact hours for the five podcasts in this program. To obtain contact hours, you must complete this Education Activity and post-test
before July 24, 2013.
For United States:
Click here to
confirm that your state will accept the CE credits gained through this
program.
For Canada:
Click here to
confirm that your province will accept the CE credits gained through this
program.
The eCysticFibrosis Review Volume 3 series will consist of a monthly review of journal literature by key, pertinent topics, emailed as either a newsletter or podcast, to clinicians caring for patients with cystic fibrosis. The timely commentary on current research, best practices and clinical management issues is provided by an expert panel of cystic fibrosis specialists. The activities are delivered as 7 bi-monthly newsletters and 5 alternating podcasts. Participants will have up to 2 years to complete the 7 newsletters and 5 podcasts in order to earn CME credit.
Date of release: July 25, 2011
Expiration date: July 24, 2013
- New classes of CF therapies are on the verge of altering the treatment landscape, and clinicians must be familiar with these new agents and their place in therapy as new treatment strategies are developed.
- CF clinicians lack awareness of the effects on CF lung disease of both gene-gene interactions and interactions among genetic and environmental variables, with a consequent increased risk of poorer patient outcomes.
- Very recent developments in strategies for treating P. aeruginosa, using existing as well as new antibiotics are only beginning to penetrate the awareness of clinicians who should be familiarized with the most effective means of treating this dangerous pathogen.
- CF clinicians lack adequate clinical guidance in managing pulmonary exacerbations.
- CF clinicians are not aware of and/or are not advocating existing strategies to improve patient adherence to antibiotic medications.
After participating in these activities the participant will demonstrate the ability to:
- Evaluate new and emerging disease modifying CF treatments and appropriate clinical strategies for their use.
- Explain the importance of controlling environmental modifiers of CF lung disease and the latest clinically relevant data regarding generic modifiers.
- Demonstrate a comprehensive foundational knowledge of P. aeruginosa.
- Distinguish between existing and newly available antibiotic agents, alone or as combination therapy.
- Adequately manage pulmonary exacerbations.
- Identify factors and appropriate precautions to slow the incidence of Multiple Antibiotic-Resistant P. aeruginosa (MARPA).
- Incorporate evidence-based strategies to improve patient adherence to antibiotic medications.
- Incorporate evidence-based strategies to improve PERT adherence.
- Implement better patient nutrition plans.
A passing grade of 70% or higher on the post-test/evaluation
is required to receive CE credit. There are no fees for this activity.
The Johns Hopkins University School of Medicine takes responsibility for the
content, quality and scientific integrity of this CME/CE activity.
This activity has been developed for Pulmonologists, Pediatric Pulmonologists,
Gastroenterologists, Pediatricians, Infectious disease specialists, Respiratory
therapists, Dieticians, Nutritionists, Nurses, and Physical
therapists.
The Office of Continuing Medical Education (CME) at the Johns Hopkins University School of Medicine is committed to protecting the privacy of its members and customers. Johns Hopkins University SOM CME maintains its Internet site as an information resource and service for physicians, other health professionals and the public.
Continuing Medical Education at the Johns Hopkins University School of Medicine will keep your personal and credit information confidential when you participate in a CME Internet based program. Your information will never be given to anyone outside of the Johns Hopkins University School of Medicine’s CME program. CME collects only the information necessary to provide you with the services that you request.
As a provider approved by the Accreditation Council for Continuing Medical Education (ACCME), it is the policy of the Johns Hopkins University School of Medicine Office of Continuing Medical Education (OCME) to require signed disclosure of the existence of financial relationships with industry from any individual in a position to control the content of a CME activity sponsored by OCME. Members of the Planning Committee are required to disclose all relationships regardless of their relevance to the content of the activity. Faculty are required to disclose only those relationships that are relevant to their specific presentation. The following relationships have been reported for this activity:
Michael P. Boyle, MD, FCCP discloses that he has received grants for clinical research from Vertex Pharmaceuticals, Inc. and is a consultant for Genentech, Inc., Gilead Sciences, Inc. and Bayer.
Peter J. Mogayzel, Jr, MD, PhD discloses that he has no financial relationship with commercial supporters.
Meghan Ramsay, MS, CRNP discloses that she has no financial relationship with commercial supporters.
Donna W. Peeler, RN discloses that she has no financial relationship with commercial supporters.
The opinions and recommendations expressed by
faculty and other experts whose input is included in this program are their
own. This enduring material is produced for educational purposes only. Use of Johns Hopkins University name implies review of educational format design and approach. Please review the complete prescribing information
of specific drugs or combination of drugs, including indications, contraindications,
warnings and adverse effects before administering pharmacologic therapy
to patients.
Pentium 800 processor or greater, Windows 98/NT/200/XP or Mac OS 9/X, Microsoft Internet Explorer 5.5 or later, Windows Media Player 9.0 or later, 128 MB of RAM Monitor settings: High color at 800 x 600 pixels, Sound card and speakers, Adobe Acrobat Reader.
Copyright © Presented by JHUSOM and IJHN in collaboration with DKBmed.
|
